Thermo Fisher Scientific Reports Record 2007 Fourth Quarter Revenues and Operating Performance; Provides Guidanc...(olidated depreciation expense in 2007 an...)

respectively.

(j) Consolidated equity compensation expense included in both reported and

adjusted results is $11.8 and $12.5 in 2007 and 2006, respectively,

aside from the 2006 charge discussed in note (e).

(k) Pro forma results combine the results of the company with the pre-

merger results of Fisher Scientific International Inc. Equity

compensation expense of $17.5 is included in the pro forma 2006

results.

Note: Consolidated net capital expenditures in Q4 2007 totaled $53.0.

Consolidated Statement of Income (a)

Twelve Months Ended

December December

31, % of 31, % of

(In millions except per share 2007 Revenues 2006 Revenues

amounts)

Revenues $9,746.4 $3,791.6

Costs and Operating Expenses

(e)(i)(j):

Cost of revenues 5,820.3 59.7% 2,210.2 58.3%

Selling, general and

administrative expenses 2,099.7 21.5% 952.7 25.1%

Amortization of acquisition-

related intangible assets 571.1 5.9% 170.8 4.5%

Research and development expenses 238.7 2.4% 170.2 4.5%

Restructuring and other costs, net

(d) 42.2 0.4% 45.7 1.2%

8,772.0 90.0% 3,549.6 93.6%

Operating Income 974.4 10.0% 242.0 6.4%

Interest Income 46.5 16.4

Interest Expense (f) (139.8) (51.9)

Other Income, Net (g) 0.2 2.9

Income from Continui
'/>"/>